Pages that link to "Q38033116"

The following pages link to AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches (Q38033116):

Displaying 35 items.

• Drugging the unfolded protein response in acute leukemias (Q26801114) (← links)
• ETO family protein Mtgr1 mediates Prdm14 functions in stem cell maintenance and primordial germ cell formation (Q28589379) (← links)
• Caspase-3 controls AML1-ETO-driven leukemogenesis via autophagy modulation in a ULK1-dependent manner (Q33707343) (← links)
• Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations. (Q34106837) (← links)
• Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression. (Q35904946) (← links)
• MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO. (Q35962533) (← links)
• Targeted drug discovery for pediatric leukemia (Q36989223) (← links)
• Drosophila as a model to study the role of blood cells in inflammation, innate immunity and cancer. (Q37453657) (← links)
• The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment (Q37727786) (← links)
• Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors (Q38263126) (← links)
• Epigenetic alterations in acute myeloid leukemias (Q38264968) (← links)
• Pontin is a critical regulator for AML1-ETO-induced leukemia (Q38310344) (← links)
• VENTX induces expansion of primitive erythroid cells and contributes to the development of acute myeloid leukemia in mice (Q38728879) (← links)
• Celastrol Induces Cell Apoptosis and Inhibits the Expression of the AML1-ETO/C-KIT Oncoprotein in t(8;21) Leukemia. (Q38773224) (← links)
• Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner (Q38883388) (← links)
• miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia (Q38917442) (← links)
• Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling. (Q39004686) (← links)
• RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1. (Q41082874) (← links)
• An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells (Q41092512) (← links)
• Peptide microarray profiling identifies phospholipase C gamma 1 (PLC-γ1) as a potential target for t(8;21) AML. (Q41815540) (← links)
• Instruction of haematopoietic lineage choices, evolution of transcriptional landscapes and cancer stem cell hierarchies derived from an AML1-ETO mouse model (Q41916176) (← links)
• A new inducible model for t(8;21) AML. (Q41916211) (← links)
• Developmental-stage-dependent transcriptional response to leukaemic oncogene expression. (Q42602670) (← links)
• Phosphatase PRL2 promotes AML1-ETO-induced acute myeloid leukemia. (Q44885193) (← links)
• Necdin modulates leukemia-initiating cell quiescence and chemotherapy response (Q47127471) (← links)
• Targeting oncoproteins for degradation by small molecules in myeloid leukemia. (Q47337952) (← links)
• Emerging Roles of MTG16 in Cell-Fate Control of Hematopoietic Stem Cells and Cancer (Q48189669) (← links)
• Recurrent Cytogenetic Abnormalities in Acute Myeloid Leukemia. (Q52817300) (← links)
• [Frequency and clinical features of ASXL2 gene mutation in acute myeloid leukemia patients with AML1- ETO fusion gene positive]. (Q54145046) (← links)
• ASXL2 regulates hematopoiesis in mice and its deficiency promotes myeloid expansion (Q59797105) (← links)
• Homoharringtonine deregulates transcriptional expression by directly binding NF-κB repressing factor (Q64388122) (← links)
• Oroxylin A, a natural anticancer flavonoid compound, induces differentiation of t(8;21)-positive Kasumi-1 and primary acute myeloid leukemia cells (Q89213115) (← links)
• RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells (Q90375158) (← links)
• The acute myeloid leukemia associated AML1-ETO fusion protein alters the transcriptome and cellular progression in a single-oncogene expressing in vitro induced pluripotent stem cell based granulocyte differentiation model (Q92205729) (← links)
• Fusion transcripts: Unexploited vulnerabilities in cancer? (Q92586512) (← links)